Results For "commercial bio tech"

8 Results

How and Why Pre-Commercial Biotech CEO Pay is Different – Part Three: East Coast vs. West Coast

by Jim Heim on October 5, 2020

Thought Leadership

In this four-part series, we examine the current state of pre-commercial biotech CEO pay, how it is tailored to the sector, and what drives differences between companies.

Read More

How and Why Pre-Commercial Biotech CEO Pay is Different – Part Two: Founders vs. Non-Founders

by Jim Heim on August 21, 2020

Thought Leadership

In this four-part series, we examine the current state of pre-commercial biotech CEO pay, how it is tailored to the sector, and what drives differences between companies.

Read More

How and Why Pre-Commercial Biotech CEO Pay is Different – Part One: Tailoring Pay to the Business

by Jim Heim on July 28, 2020

Thought Leadership

The Say-on-Pay (“SOP”) era has fostered remarkable homogenization in executive compensation program design.

Read More

Fostering Diversity in Board Pay Practices, Part Two

by Jim Heim on January 9, 2020

Thought Leadership

Crisp, transparent disclosure of pay decisions that demonstrate careful deliberations can mitigate the risks relating to being labeled an outlier.

Read More

The Meridian Advantage

We invite you to learn about what makes Meridian different.

Contact Us